4//SEC Filing
Lin Tai-An 4
Accession 0001104659-25-003464
CIK 0001773427other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:34 PM ET
Size
7.6 KB
Accession
0001104659-25-003464
Insider Transaction Report
Form 4
Lin Tai-An
Chief Scientific Officer
Transactions
- Award
Common Stock
2025-01-10+6,929→ 33,039 total - Award
Stock Option (Right to Buy)
2025-01-10+20,246→ 20,246 totalExercise: $43.00Exp: 2035-01-10→ Common Stock (20,246 underlying)
Footnotes (2)
- [F1]This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty-three percent (33%) to vest on January 10, 2026, another thirty-three percent (33%) to vest on January 10, 2027 and the remaining thirty-four percent (34%) to vest on January 10, 2028, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.
- [F2]This option shall vest in forty-eight (48) equal monthly installments following January 10, 2025, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001991985
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 4:34 PM ET
- Size
- 7.6 KB